Publication:
Validation of the vulvovaginal symptom questionnaire in Turkish women with genitourinary syndrome of menopause

dc.contributor.coauthorTekin, Arzu Bilge
dc.contributor.coauthorYassa, Murat
dc.contributor.coauthorSargin, Mehmet Akif
dc.contributor.coauthorKeskin, Ilkhan
dc.contributor.coauthorUsta, Serhat
dc.contributor.coauthorBudak, Dogus
dc.contributor.coauthorBuran, Ayca Miray
dc.contributor.coauthorTug, Niyazi
dc.contributor.departmentN/A
dc.contributor.kuauthorKalkan, Üzeyir
dc.contributor.kuprofileTeaching Faculty
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid332495
dc.date.accessioned2024-11-09T23:11:10Z
dc.date.issued2022
dc.description.abstractObjective: This study aims to psychometrically validate the Turkish version of the Vulvovaginal Symptom Questionnaire (VSQ). Methods: Postmenopausal women with and without genitourinary syndrome of menopause (GSM) were included as the target population and the control group. Psychometric properties were validated both for sexually active (21 items) and passive women (16 items). Several a priori hypotheses were formulated to assess construct validity. Scores of GSM-Assessment Tool, Female Sexual Function Index, Michigan Incontinence Severity Index, Female Genital Self-Image Scale, and Menopause Rating Scale and their correlation with VSQ scores were compared. Results: A total of 242 postmenopausal women were included. The VSQ showed good internal consistency with a Cronbach alpha coefficient of 0.822 (0.800-0.821) and 0.873 (0.853-0.870) in sexually active and passive women, respectively. Originally proposed model (4-factor model, n = 162) showed adequate fit in women with active sexuality and the 3-factor model (n = 242) showed moderate fit. The test-retest reliability was good for symptoms, emotions, and life impact subscales (intraclass correlation coefficient [ICC]: 0.846, 0.835, and 0.755, respectively) and moderate for sexual impact subscale (ICC: 0.643). More than 75% of hypotheses were confirmed. Conclusions: Our study shows successful cross-cultural adaptation and validation with sufficient psychometric properties for VSQ to be used in Turkish postmenopausal women with GSM.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue3
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume29
dc.identifier.doi10.1097/GME.0000000000001922
dc.identifier.eissn1530-0374
dc.identifier.issn1072-3714
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85125550730
dc.identifier.urihttp://dx.doi.org/10.1097/GME.0000000000001922
dc.identifier.urihttps://hdl.handle.net/20.500.14288/9582
dc.identifier.wos784964600011
dc.keywordsGenitourinary syndrome of menopause
dc.keywordsPatient-reported outcome measures
dc.keywordsReliability
dc.keywordsValidity
dc.keywordsVulvovaginal symptoms quality
dc.keywordsHealth
dc.keywordsPrevalence
dc.keywordsCriteria
dc.keywordsAtrophy
dc.languageEnglish
dc.publisherLippincott Williams and Wilkins
dc.sourceMenopause-The Journal of The North American Menopause Society
dc.subjectObstetrics
dc.subjectGynecology
dc.titleValidation of the vulvovaginal symptom questionnaire in Turkish women with genitourinary syndrome of menopause
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0001-5223-6697
local.contributor.kuauthorKalkan, Üzeyir

Files